121 related articles for article (PubMed ID: 16285562)
1. Breast density changes associated with hormone replacement therapy in postmenopausal women. Effects on the specificity and sensitivity of mammographic screening.
Patella A; Marziani R; Schippa A; Benedetti S; Mossa S; Mossa B
Eur J Gynaecol Oncol; 2005; 26(5):485-90. PubMed ID: 16285562
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography.
Laya MB; Larson EB; Taplin SH; White E
J Natl Cancer Inst; 1996 May; 88(10):643-9. PubMed ID: 8627640
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and mammographic screening.
Evans A
Clin Radiol; 2002 Jul; 57(7):563-4. PubMed ID: 12096852
[TBL] [Abstract][Full Text] [Related]
5. Mammographic density in women on postmenopausal hormone replacement therapy.
Leung W; Goldberg F; Zee B; Sterns E
Surgery; 1997 Oct; 122(4):669-73; discussion 673-4. PubMed ID: 9347841
[TBL] [Abstract][Full Text] [Related]
6. The meaning of mammographic breast density in users of postmenopausal hormone therapy.
Speroff L
Maturitas; 2002 Mar; 41(3):171-5. PubMed ID: 11886762
[No Abstract] [Full Text] [Related]
7. Mammographic density changes in perimenopausal and postmenopausal women: is effect of hormone replacement therapy predictable?
Sterns EE; Zee B
Breast Cancer Res Treat; 2000 Jan; 59(2):125-32. PubMed ID: 10817347
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
[TBL] [Abstract][Full Text] [Related]
9. Mammographic changes in postmenopausal women on hormonal replacement therapy.
Marugg RC; van der Mooren MJ; Hendriks JH; Rolland R; Ruijs SH
Eur Radiol; 1997; 7(5):749-55. PubMed ID: 9166577
[TBL] [Abstract][Full Text] [Related]
10. Short-term hormone therapy suspension and mammography recall: a randomized trial.
Buist DS; Anderson ML; Reed SD; Aiello Bowles EJ; Fitzgibbons ED; Gandara JC; Seger D; Newton KM
Ann Intern Med; 2009 Jun; 150(11):752-65. PubMed ID: 19487710
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M; Patnick J
Breast Cancer Res; 2006; 8(1):R8. PubMed ID: 16417651
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone therapy and change in mammographic density.
Greendale GA; Reboussin BA; Slone S; Wasilauskas C; Pike MC; Ursin G
J Natl Cancer Inst; 2003 Jan; 95(1):30-7. PubMed ID: 12509398
[TBL] [Abstract][Full Text] [Related]
13. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
[TBL] [Abstract][Full Text] [Related]
14. Use of hormone therapy and isoflavones and mammographic density in Spain.
Isidoro B; Lope V; Whelan D; Pedraz C; Sánchez-Contador C; Santamariña C; Moreo P; Vidal C; Salas-Trejo D; Ederra M; Aragonés N; Pérez-Gómez B; Pollán M
Menopause; 2016 May; 23(5):556-64. PubMed ID: 26731688
[TBL] [Abstract][Full Text] [Related]
15. Mammographic density, response to hormones, and breast cancer risk.
Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
[TBL] [Abstract][Full Text] [Related]
16. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
17. Effects of a short-term suspension of hormone replacement therapy on mammographic density.
Colacurci N; Fornaro F; De Franciscis P; Mele D; Palermo M; del Vecchio W
Fertil Steril; 2001 Sep; 76(3):451-5. PubMed ID: 11532463
[TBL] [Abstract][Full Text] [Related]
18. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and accuracy of mammographic screening.
Kavanagh AM; Mitchell H; Giles GG
Lancet; 2000 Jan; 355(9200):270-4. PubMed ID: 10675074
[TBL] [Abstract][Full Text] [Related]
20. High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study.
Sala E; Warren R; McCann J; Duffy S; Luben R; Day N
Int J Epidemiol; 2000 Aug; 29(4):629-36. PubMed ID: 10922338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
